BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10825385)

  • 1. Doxorubicin impairs crossbridge turnover kinetics in skinned cardiac trabeculae after acute and chronic treatment.
    de Beer EL; Bottone AE; van Der Velden J; Voest EE
    Mol Pharmacol; 2000 Jun; 57(6):1152-7. PubMed ID: 10825385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexrazoxane pre-treatment protects skinned rat cardiac trabeculae against delayed doxorubicin-induced impairment of crossbridge kinetics.
    de Beer EL; Bottone AE; van Rijk MC; van der Velden J; Voest EE
    Br J Pharmacol; 2002 Apr; 135(7):1707-14. PubMed ID: 11934811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of the actin-myosin interaction in permeabilized cardiac trabeculae after chronic doxorubicin treatment.
    Bottone AE; Voest EE; de Beer EL
    Clin Cancer Res; 1998 Apr; 4(4):1031-7. PubMed ID: 9563899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voluntary wheel running in rats receiving doxorubicin: effects on running activity and cardiac myosin heavy chain.
    Hydock DS; Wonders KY; Schneider CM; Hayward R
    Anticancer Res; 2009 Nov; 29(11):4401-7. PubMed ID: 20032385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction.
    Hydock DS; Lien CY; Schneider CM; Hayward R
    Med Sci Sports Exerc; 2008 May; 40(5):808-17. PubMed ID: 18408619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent effects of doxorubicin on cardiac gene expression.
    Boucek RJ; Miracle A; Anderson M; Engelman R; Atkinson J; Dodd DA
    J Mol Cell Cardiol; 1999 Aug; 31(8):1435-46. PubMed ID: 10423342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anthracyclines enhance tension development in cardiac muscle by direct interaction with the contractile system.
    Bottone AE; de Beer EL; Voest EE
    J Mol Cell Cardiol; 1997 Mar; 29(3):1001-8. PubMed ID: 9152861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY; Najjar TA; Alashari M
    J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
    Abd El-Gawad HM; El-Sawalhi MM
    J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats.
    Zhou S; Heller LJ; Wallace KB
    Toxicol Appl Pharmacol; 2001 Aug; 175(1):60-7. PubMed ID: 11509027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute exercise protects against doxorubicin cardiotoxicity.
    Wonders KY; Hydock DS; Schneider CM; Hayward R
    Integr Cancer Ther; 2008 Sep; 7(3):147-54. PubMed ID: 18815146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in crossbridge mechanical properties in diabetic rat cardiomyopathy.
    Joseph T; Coirault C; Dubourg O; Lecarpentier Y
    Basic Res Cardiol; 2005 May; 100(3):231-9. PubMed ID: 15645163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the influence of modulation of P-glycoprotein by a multiple dosing regimen of tamoxifen on the pharmacokinetics and toxicodynamics of doxorubicin.
    Darvari R; Boroujerdi M
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):497-509. PubMed ID: 15937726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of doxorubicin chronic toxicity in metallothionein-overexpressing transgenic mouse heart.
    Sun X; Zhou Z; Kang YJ
    Cancer Res; 2001 Apr; 61(8):3382-7. PubMed ID: 11309296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine is protective against doxorubicin-induced cardiotoxicity in rat.
    Kelishomi RB; Ejtemaeemehr S; Tavangar SM; Rahimian R; Mobarakeh JI; Dehpour AR
    Toxicology; 2008 Jan; 243(1-2):96-104. PubMed ID: 17988779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different iron chelators as protective agents against acute doxorubicin-induced cardiotoxicity.
    Voest EE; van Acker SA; van der Vijgh WJ; van Asbeck BS; Bast A
    J Mol Cell Cardiol; 1994 Sep; 26(9):1179-85. PubMed ID: 7815460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats.
    Pantos C; Mourouzis I; Markakis K; Dimopoulos A; Xinaris C; Kokkinos AD; Panagiotou M; Cokkinos DV
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):333-9. PubMed ID: 17560116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rehabilitative exercise in a rat model of doxorubicin cardiotoxicity.
    Hydock DS; Lien CY; Jensen BT; Parry TL; Schneider CM; Hayward R
    Exp Biol Med (Maywood); 2012 Dec; 237(12):1483-92. PubMed ID: 23354407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of acidosis on maximum shortening velocity and force-velocity relation of skinned rat cardiac muscle.
    Ricciardi L; Bottinelli R; Canepari M; Reggiani C
    J Mol Cell Cardiol; 1994 May; 26(5):601-7. PubMed ID: 8072014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?
    Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M
    Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.